

Even though AEP has come to a close, Cigna would like to remind you that you still have time to facilitate and submit health risk assessments (HRAs) for your customers. Agents have until December 21, 2022 to submit the HRA for any customer applications taken from October 1 – December 7 of 2022.
Don't miss out on Cigna's amazing HRA incentives! For your 2023 effectives, you can earn $125 when you enroll your Cigna Medicare Advantage customers in an eligible Medicare D-SNP or C-SNP plan and facilitate an HRA with Cigna's Value Based Enrollment initiative.
In addition to receiving increased payments of $125 for enrollments with HRAs in eligible plans, you will also be able to earn $75 for each HRA that you facilitate with your other Cigna Medicare Advantage customers. Facilitating an HRA is also a great way to obtain referrals and leads for the upcoming Medicare open enrollment period (OEP). Click here to learn more about Cigna's HRA incentives.
Reminder: Outside of AEP, agents must complete the HRA with the customer, and submit the completed HRA within the HRA tool within 10 calendar days of the member's application sign date to ensure a positive customer experience. As a best practice, make sure to confirm the date and time of your next appointment with your customer prior to reaching out again.
Don't have a MedCareValue page yet?
Get Your FREE Site >
Read MoreMedigap, SSBCI, and Delaware D-SNP Information
Read MoreAEP is coming to a close, but the Integrated Care SEP* can still be used
Read MoreAEP support, UCard shipments and SSBCI verification
Read MoreBroker Insights: The newsletter for all Medicare brokers - 11.2
Read MoreThe podcast that brokers can’t stop talking about is back!
Read More2026 Medicare Advantage Star Rating Sheets and more
-01.png)
Choosing an FMO to work with is not just about having access to top insurance products and commissions, it’s about finding a one-on-one agent service that is prepared to meet your needs.
Get to know us, and see how we can help you take your business to the next level.